Global technology competition is increasingly defined by the ways in which states support their own tech ecosystems while trying to impede those of their rivals. Here, we examine how China supports new tech industries not just through subsidies but through conjuring up state-led demand, and dissect China’s role in the US pharmaceutical supply chain to assess how much risk the sector faces from American tariffs and import restrictions.